Nutritionally physiological cell culture medium and 3D culture influence breast tumour proteomics and anti-cancer drug effectiveness

Many drugs have been discontinued during phase II/III breast cancer clinical trials due to lack of clinical efficacy, indicating shortcomings in predictive value of preclinical data. Nutrient availability in the tumour cell microenvironment and the dimensionality of in vitro tumour cells likely impa...

Full description

Saved in:
Bibliographic Details
Main Authors: Xiaodan Zhang, Tianhong Cheng, Ellie Cho, Wenjia Lu, Delphine Denoyer, Paul McMillan, Kalyan Shobhana, Swati Varshney, Nicholas A. Williamson, Alastair Stewart
Format: Article
Language:English
Published: Elsevier 2024-12-01
Series:Pharmacological Research
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S104366182400464X
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850113828872781824
author Xiaodan Zhang
Tianhong Cheng
Ellie Cho
Wenjia Lu
Delphine Denoyer
Paul McMillan
Kalyan Shobhana
Swati Varshney
Nicholas A. Williamson
Alastair Stewart
author_facet Xiaodan Zhang
Tianhong Cheng
Ellie Cho
Wenjia Lu
Delphine Denoyer
Paul McMillan
Kalyan Shobhana
Swati Varshney
Nicholas A. Williamson
Alastair Stewart
author_sort Xiaodan Zhang
collection DOAJ
description Many drugs have been discontinued during phase II/III breast cancer clinical trials due to lack of clinical efficacy, indicating shortcomings in predictive value of preclinical data. Nutrient availability in the tumour cell microenvironment and the dimensionality of in vitro tumour cells likely impact on drug responsiveness. Global proteomics experiments were conducted to assess the impact of nutrient availability and dimensionality of culture. Protein set enrichment analyses identified “pathways in cancer”, “focal adhesion” and “ECM receptor in interaction” related to cell culture dimensionality in MDA-MB-231 cells. In MCF-7 cells, 4 pathways were influenced by medium composition, and 2 pathways were influenced by cell culture dimensionality (2D vs. 3D). These pathways were also identified using KEGG analyses. Eight drugs were selected for investigation according to the differential expression of their putative or known target proteins. The influence of medium composition on drug effectiveness was explored using the “Melbourne Medium” (MM), developed to have nutritionally physiological levels of metabolites as compared with conventional (hyper-nutritional) cell culture medium (CM). The influence of dimensionality on drug effectiveness was also explored, using an innovative 3D viability assessment combining automated confocal microscopy and image analysis. Dimensionality of culture appeared to have a greater influence on the proteome and drug effects than variation in nutrient levels. The number of differentially expressed proteins in the different media was greater in 2D than 3D. We conclude that the risk of qualifying inactive compounds in preclinical assessment may be mitigated using additional models incorporating physiological media and 3-dimensionality.
format Article
id doaj-art-e44fe74df1654e5bada7fdbc506d06f2
institution OA Journals
issn 1096-1186
language English
publishDate 2024-12-01
publisher Elsevier
record_format Article
series Pharmacological Research
spelling doaj-art-e44fe74df1654e5bada7fdbc506d06f22025-08-20T02:37:03ZengElsevierPharmacological Research1096-11862024-12-0121010751910.1016/j.phrs.2024.107519Nutritionally physiological cell culture medium and 3D culture influence breast tumour proteomics and anti-cancer drug effectivenessXiaodan Zhang0Tianhong Cheng1Ellie Cho2Wenjia Lu3Delphine Denoyer4Paul McMillan5Kalyan Shobhana6Swati Varshney7Nicholas A. Williamson8Alastair Stewart9Department of Biochemistry and Pharmacology, The University of Melbourne, VIC, Australia; ARC Centre for Personalised Therapeutics Technologies, Melbourne, VIC, AustraliaDepartment of Biochemistry and Pharmacology, The University of Melbourne, VIC, Australia; ARC Centre for Personalised Therapeutics Technologies, Melbourne, VIC, AustraliaDepartment of Biochemistry and Pharmacology, The University of Melbourne, VIC, Australia; The Biological Optical Microscopy Platform (BOMP), The University of Melbourne, VIC, AustraliaDepartment of Biochemistry and Pharmacology, The University of Melbourne, VIC, Australia; ARC Centre for Personalised Therapeutics Technologies, Melbourne, VIC, AustraliaDepartment of Biochemistry and Pharmacology, The University of Melbourne, VIC, Australia; ARC Centre for Personalised Therapeutics Technologies, Melbourne, VIC, AustraliaDepartment of Biochemistry and Pharmacology, The University of Melbourne, VIC, Australia; The Biological Optical Microscopy Platform (BOMP), The University of Melbourne, VIC, AustraliaDepartment of Biochemistry and Pharmacology, The University of Melbourne, VIC, Australia; The Biological Optical Microscopy Platform (BOMP), The University of Melbourne, VIC, AustraliaMelbourne Mass Spectrometry and Proteomics Facility, Bio21 Molecular Science & Biotechnology Institute, The University of Melbourne, VIC, AustraliaMelbourne Mass Spectrometry and Proteomics Facility, Bio21 Molecular Science & Biotechnology Institute, The University of Melbourne, VIC, AustraliaDepartment of Biochemistry and Pharmacology, The University of Melbourne, VIC, Australia; ARC Centre for Personalised Therapeutics Technologies, Melbourne, VIC, Australia; Correspondence to: Department of Biochemistry and Pharmacology, The University of Melbourne, VIC 3010, Australia.Many drugs have been discontinued during phase II/III breast cancer clinical trials due to lack of clinical efficacy, indicating shortcomings in predictive value of preclinical data. Nutrient availability in the tumour cell microenvironment and the dimensionality of in vitro tumour cells likely impact on drug responsiveness. Global proteomics experiments were conducted to assess the impact of nutrient availability and dimensionality of culture. Protein set enrichment analyses identified “pathways in cancer”, “focal adhesion” and “ECM receptor in interaction” related to cell culture dimensionality in MDA-MB-231 cells. In MCF-7 cells, 4 pathways were influenced by medium composition, and 2 pathways were influenced by cell culture dimensionality (2D vs. 3D). These pathways were also identified using KEGG analyses. Eight drugs were selected for investigation according to the differential expression of their putative or known target proteins. The influence of medium composition on drug effectiveness was explored using the “Melbourne Medium” (MM), developed to have nutritionally physiological levels of metabolites as compared with conventional (hyper-nutritional) cell culture medium (CM). The influence of dimensionality on drug effectiveness was also explored, using an innovative 3D viability assessment combining automated confocal microscopy and image analysis. Dimensionality of culture appeared to have a greater influence on the proteome and drug effects than variation in nutrient levels. The number of differentially expressed proteins in the different media was greater in 2D than 3D. We conclude that the risk of qualifying inactive compounds in preclinical assessment may be mitigated using additional models incorporating physiological media and 3-dimensionality.http://www.sciencedirect.com/science/article/pii/S104366182400464Xmicrophysiological systems3D cytotoxicitypaclitaxeltubulintopoisomerase
spellingShingle Xiaodan Zhang
Tianhong Cheng
Ellie Cho
Wenjia Lu
Delphine Denoyer
Paul McMillan
Kalyan Shobhana
Swati Varshney
Nicholas A. Williamson
Alastair Stewart
Nutritionally physiological cell culture medium and 3D culture influence breast tumour proteomics and anti-cancer drug effectiveness
Pharmacological Research
microphysiological systems
3D cytotoxicity
paclitaxel
tubulin
topoisomerase
title Nutritionally physiological cell culture medium and 3D culture influence breast tumour proteomics and anti-cancer drug effectiveness
title_full Nutritionally physiological cell culture medium and 3D culture influence breast tumour proteomics and anti-cancer drug effectiveness
title_fullStr Nutritionally physiological cell culture medium and 3D culture influence breast tumour proteomics and anti-cancer drug effectiveness
title_full_unstemmed Nutritionally physiological cell culture medium and 3D culture influence breast tumour proteomics and anti-cancer drug effectiveness
title_short Nutritionally physiological cell culture medium and 3D culture influence breast tumour proteomics and anti-cancer drug effectiveness
title_sort nutritionally physiological cell culture medium and 3d culture influence breast tumour proteomics and anti cancer drug effectiveness
topic microphysiological systems
3D cytotoxicity
paclitaxel
tubulin
topoisomerase
url http://www.sciencedirect.com/science/article/pii/S104366182400464X
work_keys_str_mv AT xiaodanzhang nutritionallyphysiologicalcellculturemediumand3dcultureinfluencebreasttumourproteomicsandanticancerdrugeffectiveness
AT tianhongcheng nutritionallyphysiologicalcellculturemediumand3dcultureinfluencebreasttumourproteomicsandanticancerdrugeffectiveness
AT elliecho nutritionallyphysiologicalcellculturemediumand3dcultureinfluencebreasttumourproteomicsandanticancerdrugeffectiveness
AT wenjialu nutritionallyphysiologicalcellculturemediumand3dcultureinfluencebreasttumourproteomicsandanticancerdrugeffectiveness
AT delphinedenoyer nutritionallyphysiologicalcellculturemediumand3dcultureinfluencebreasttumourproteomicsandanticancerdrugeffectiveness
AT paulmcmillan nutritionallyphysiologicalcellculturemediumand3dcultureinfluencebreasttumourproteomicsandanticancerdrugeffectiveness
AT kalyanshobhana nutritionallyphysiologicalcellculturemediumand3dcultureinfluencebreasttumourproteomicsandanticancerdrugeffectiveness
AT swativarshney nutritionallyphysiologicalcellculturemediumand3dcultureinfluencebreasttumourproteomicsandanticancerdrugeffectiveness
AT nicholasawilliamson nutritionallyphysiologicalcellculturemediumand3dcultureinfluencebreasttumourproteomicsandanticancerdrugeffectiveness
AT alastairstewart nutritionallyphysiologicalcellculturemediumand3dcultureinfluencebreasttumourproteomicsandanticancerdrugeffectiveness